GlassScriptPhysician profile
Katherine Lijoi
NPI 1023178449
$1,369.52
in general payments reported to CMS, 2019-2025
20 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $426 · 2023: $225 · 2024: $218 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $244.91 | 2022-2024 | Freestyle Libre 2, Freestyle Libre 3, Eterna |
| Medtronic, INC. | $189.83 | 2022-2025 | Linq II |
| Abbvie INC. | $169.09 | 2022-2024 | |
| Boston Scientific Corporation | $151.73 | 2021-2025 | Wavewriter Alpha Prime 16, Watchman Flx |
| Lilly USA, LLC | $127.22 | 2022 | |
| Edwards Lifesciences Corporation | $100.94 | 2025 | Sapien 3 Ultra Resilia |
| Philips North America LLC | $61.40 | 2022 | |
| Impulse Dynamics (USA) INC. | $44.76 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $39.45 | 2022 | |
| Novo Nordisk INC | $28.08 | 2022-2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $26.74 | 2022 | |
| Nevro Corp. | $25.82 | 2022-2023 | Senza |
| Inspire Medical Systems, INC. | $24.59 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $24.05 | 2025 | Aptima |
| Corcept Therapeutics | $21.32 | 2025 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.28 | 2023 | Otezla, Repatha |
| Glaxosmithkline, LLC. | $17.71 | 2025 | Trelegy Ellipta |
| Pfizer INC. | $17.65 | 2024 | |
| Sanofi-Aventis U.S. LLC | $16.63 | 2022 | |
| Abiomed | $16.32 | 2024 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Lijoi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.